Gyre Therapeutics Inc. (GYRE)
undefined
undefined%
At close: undefined
10.30
6.19%
After-hours Dec 13, 2024, 05:53 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01
Revenue 113.45M 794.00K 7.34M 20.95M - 6.00K 1.02M 399.00K 1.75M 275.00K 3.63M 57.86M 97.64M 85.71M 25.06M 20.09M 11.58M 27.54M 1.18M 3.74M 2.46M 2.29M 1.70M
Cost of Revenue 4.64M 798.00K 7.38M 9.16M 43.86M 21.47M 12.85M 10.55M 5.96M 5.27M 6.56M - - - 691.00K 749.00K 715.42K 457.25K 480.93K 198.45K 743.00K 244.00K -
Gross Profit 108.81M -4.00K -42.00K 11.79M -43.86M -21.47M -11.83M -10.16M -4.21M -4.99M -2.93M 57.86M 97.64M 85.71M 24.37M 19.34M 10.86M 27.08M 698.98K 3.54M 1.72M 2.04M 1.70M
Operating Income -67.23M -8.61M -87.89M -57.37M -57.28M -33.82M -21.82M -20.42M -13.80M -29.71M -47.22M -8.14M -9.74M 13.12M -40.33M -28.14M -31.77M -403.69K -29.94M -24.39M -20.06M -21.00M -8.75M
Interest Income - 537.00K 39.00K 1.13M 2.10M 3.77M 261.00K 3.47M 518.00K 585.00K 784.00K 1.07M 1.22M 1.46M 1.05M 2.73M - - - - - - -
Pretax Income -76.97M -7.89M -87.93M -56.24M -55.18M -30.05M -21.56M -16.95M -14.76M -29.14M -46.70M -7.10M -8.53M 14.43M -39.49M -25.66M -28.07B -1.24B - -24.40M - - -
Net Income -92.93M 2.30M -87.93M -55.54M -52.89M -30.05M -21.56M -16.95M -14.76M -32.62M -46.70M -7.00M -8.53M 10.90M -39.40M -25.66M -28.07M 2.10M -28.99M -24.03M -19.39M -21.07M -7.30M
Selling & General & Admin 75.82M 17.37M 18.96M 16.18M 13.42M 12.35M 9.99M 9.26M 9.59M 10.17M 12.01M 13.19M 12.17M 8.05M 8.17M 6.50M 8.01M 5.70M 6.39M 5.16M 3.60M 4.13M 2.30M
Research & Development 13.78M 13.04M 68.89M 52.98M 43.86M 21.47M 12.85M 11.55M 5.96M 19.50M 38.84M 49.09M 95.22M 64.55M 40.18M 40.98M 34.62M 21.79M 24.25M 22.77M 18.18M 16.24M 8.15M
Other Expenses 86.44M -517.00K -78.00K 568.00K -46.00K 1.65M 261.00K 86.00K - 318.00K 518.00K 1.04M - - 51.28M 32.01M 27.33B 16.77B - - - - -
Operating Expenses 176.04M 30.40M 87.85M 69.16M 57.28M 33.83M 22.84M 20.82M 15.55M 29.67M 50.84M 62.28M 107.38M 72.60M 64.70M 47.48M 42.63M 27.48M 30.64M 27.93M 21.78M 23.05M 10.45M
Interest Expense - 717.00K - - - - - - 1.48M 23.00K 53.00K 86.00K 132.00K 153.00K 217.00K 251.00K - - - - - - -
Selling & Marketing Expenses 61.16M 54.24M 44.65M - - - - - - - - - - - - - -8.00B -5.69B - - - - -
Cost & Expenses 180.68M 31.20M 95.23M 78.32M 57.28M 33.83M 22.84M 20.82M 15.55M 29.67M 50.84M 62.28M 107.38M 72.60M 65.39M 48.23M 43.35M 27.94M 31.12M 28.13M 22.52M 23.29M 10.45M
Income Tax 8.52M 348.00K -39.00K -699.00K -2.29M 3.77M -173.00K 3.08M 518.00K 3.48M 7.00K -101.00K -2.48M 3.53M -88.00K -4.28M -3.70M -2.50M -949.39K -368.04K 19.39M 21.07M 7.30M
Shares Outstanding (Basic) 65.83M 76.74M 30.64M 19.18M 12.00M 11.21M 3.42M 778.78K 295.27K 321.72K 320.38K 318.82K 301.31K 271.84K 244.16K 234.90K 187.82K 129.48K 2.50K 2.09K 1.04K 2.60K 2.60K
Shares Outstanding (Diluted) 65.83M 75.69M 30.64M 19.18M 12.00M 11.21M 3.42M 778.78K 295.27K 321.72K 320.38K 318.82K 301.31K 287.15K 244.16K 234.90K 187.82K 129.48K 2.50K 2.09K 1.04K 2.60K 2.60K
EPS (Basic) -1.41 0.04 -2.87 -2.9 -4.41 -2.68 -6.3 -21.76 -49.99 -101.4 -145.78 -21.95 -28.31 39.90 -161.39 -109.24 -149.47 -9.45 -11.62K -11.51K -18.68K -8.10K -2.81K
EPS (Diluted) -1.41 0.03 -2.87 -2.9 -4.41 -2.68 -6.3 -21.76 -49.99 -101.4 -145.78 -21.95 -28.31 37.80 -161.39 -109.24 -149.47 -9.45 -11.62K -11.51K -18.68K -8.10K -2.81K
EBITDA 20.33M 10.33M -87.60M -57.37M -57.28M -33.82M -21.82M -16.95M -12.81M -29.71M -47.22M -8.14M -9.74M 13.12M -40.33M -28.14M -30.86M 417.23K -29.14M -23.13M -20.06M -21.00M -8.75M
Depreciation & Amortization 1.11M 1.13M 290.00K 138.00K 146.00K 149.00K 173.00K 389.00K 470.00K 351.00K 547.00K 2.21M 2.48M 2.00M 1.83M 1.80M 907.16K 820.92K 803.18K 766.34K - - -